In the in vitro binding assay study, using a tritium labeled compound, [3H]HY-2-15, revealed that HY-2-15 has high binding affinities for α-syn aggregations in MSA and PD postmortem brain tissues as well as for misfolded tau proteins in AD, PSP, and CBD brain tissue homogenates. This evidence concerns the gene MAPT and Alzheimer disease.